1 body residence time was calculated after the
dosimetric administration from total-body counts obtaine
2 The relative
dosimetric advantage of a given radiopharmaceutical comp
3 e emitter 33P appears to offer a substantial
dosimetric advantage over energetic beta-particle emitte
4 The CE emitter 117mSn offers a large
dosimetric advantage over energetic beta-particle emitte
5 These probes or
dosimetric agents demonstrated good selectivity, two-sig
6 Dosimetric analyses indicate that scavenging enzymes bar
7 The pharmacokinetic and
dosimetric analyses were further determined using WinNon
8 ive data obtained are useful for kinetic and
dosimetric analyses, which may be applied to study other
9 Our
dosimetric analysis demonstrated a (64)Cu effective dose
10 The
dosimetric analysis of 123I-IAZA in 6 healthy volunteers
11 SPECT resolution is not sufficient to enable
dosimetric analysis of anatomic features of the thicknes
12 was derived from clinical experience, and a
dosimetric analysis of lung and tumor absorbed dose woul
13 Dosimetric analysis showed that (225)Ac-treated metastas
14 Dosimetric analysis showed the binding affinity of amelo
15 Dosimetric analysis was also performed for a lung-surfac
16 ermined in anesthetized dogs as well as by a
dosimetric analysis.
17 of this work was to investigate the relevant
dosimetric and luminescent properties of MgO:Li3%,Ce0.03
18 study aimed at identifying patient-specific
dosimetric and nondosimetric factors predicting outcome
19 by the region-of-interest method, after both
dosimetric and therapeutic administrations.
20 ve of 47 patients were treated with a single
dosimetric and therapeutic dose.
21 nlabeled antibody was given prior to labeled
dosimetric and therapeutic doses to improve biodistribut
22 A single-cell
dosimetric approach is required to evaluate the efficacy
23 f SFGSGFGGGY to amelogenins was confirmed by
dosimetric binding of amelogenins or TRAP with [(3)H]pep
24 nity of CK14 and amelogenin was confirmed by
dosimetric binding of CK14 to recombinant amelogenin (rM
25 The GlcNAc affinity was confirmed by
dosimetric binding of rM179 with [14C]GlcNAc, specific b
26 Minimal toxicity,
dosimetric calculations and clinical assessment indicate
27 Dosimetric calculations are performed with an increasing
28 Dosimetric calculations based on the measured time-integ
29 Biodistribution assays and
dosimetric calculations established that scVEGF/(177)Lu
30 ive study were used to perform retrospective
dosimetric calculations for (131)I therapy for the norma
31 Dosimetric calculations in relation to PRRT have been co
32 Even though
dosimetric calculations reveal that the doses applied in
33 Dosimetric calculations were performed using the MIRD fo
34 Dosimetric calculations, assuming nonreceptor targeting,
35 enuation correction and allows more accurate
dosimetric calculations.
36 This study aimed to investigate the
dosimetric characteristics of an isocentrically shielded
37 maging agents, light delivery components and
dosimetric components.
38 e radiotherapy and to evaluate the resulting
dosimetric consequences to surrounding organs at risk.
39 , the photoactivating light and to establish
dosimetric correlation of light and drug parameters to P
40 Retrospective
dosimetric correlations were conducted and related to re
41 nformal optimized planning provided improved
dosimetric coverage compared with standard techniques.
42 Each series looks at various
dosimetric cutpoints that predict for freedom from bioch
43 Yet,
dosimetric data acquired for 4 d or more may be insuffic
44 safety, and tolerability, as well as provide
dosimetric data and evaluate the imaging properties, of
45 The generated
dosimetric database of radiotracers using new-generation
46 vity that can safely be administered without
dosimetric determination of the maximum tolerable activi
47 The therapy is delivered in 2 parts, a
dosimetric dose and a therapeutic dose.
48 ioimmunotherapy regimen is administered as a
dosimetric dose followed by a therapeutic dose.
49 The biodistribution of the
dosimetric dose is assessed by quantitative calculations
50 Nine patients received a
dosimetric dose of 370 MBq (10 mCi).
51 assigned to receive iodine-131 tositumomab (
dosimetric dose of 5 mCi on day -19 and therapeutic dose
52 This consisted of a
dosimetric dose of tositumomab and 131I-labeled tositumo
53 The single therapeutic dose following a
dosimetric dose was adjusted to give the same total body
54 A single
dosimetric dose was followed at 7 to 14 days by the pati
55 mnants after surgery, even though the median
dosimetric dose was only 40 MBq.
56 ells/mm(3)) was given 7 to 14 days after the
dosimetric dose.
57 ) based on the clearance rate of a preceding
dosimetric dose.
58 sing NHL were first studied with one or more
dosimetric doses of approximately 5 mCi of 1311 anti-B1
59 Six patients received
dosimetric doses only.
60 once during therapy with SPECT to assist in
dosimetric estimation.
61 s of improving therapeutic outcomes, such as
dosimetric estimations, high-dose therapies, multiple fr
62 Dosimetric evaluation at the luminal mucosa performed on
63 hat OR, CR, and PFS were associated with the
dosimetric factors and equivalent biologic effect.
64 gnificantly with almost all of the evaluated
dosimetric factors, including equivalent biologic effect
65 The
dosimetric goal was 85 Gy in 7 days to a conformal volum
66 This series of five
dosimetric head and brain models will allow more precise
67 5 or > 4:1 for EudraCT no. 2007-007241-12 at
dosimetric imaging).
68 The
dosimetric implication of these results may be significa
69 igated as a tool for providing parameters of
dosimetric importance during radionuclide therapy.
70 agents and, from these data, to estimate the
dosimetric improvement to be expected from use of the mo
71 ty indicators for the CATPHAN 600 phantom; -
dosimetric indicators of exposure (DLP i CTDIvol).
72 omab and (131)I-tositumomab therapy included
dosimetric (
low activity) and therapeutic (high activity
73 ance, utilizing both control point tests and
dosimetric measurements are presented.
74 Dosimetric measurements were performed with thermolumine
75 dy dose of radiation, including a simplified
dosimetric method based on just three data points, are d
76 orrespondence is not reached either with the
dosimetric method or with either method in combination w
77 ionship in a manner not predicted by current
dosimetric methodologies.
78 The aim of this work was to develop
dosimetric methods and calculate tumor-absorbed radiatio
79 All three
dosimetric methods yielded bladder and rectal doses high
80 A
dosimetric model describing both high-rate and low-rate
81 A substantial revision to the
dosimetric model of the adult head and brain originally
82 Nuclear Medicine recently adopted a detailed
dosimetric model of the head and brain for the adult.
83 used for the development of a biokinetic and
dosimetric model.
84 ques, better methods for pharmacokinetic and
dosimetric modeling, and new methods of isotope delivery
85 (ICRP) is an organization that also supplies
dosimetric models and technical data, for use in providi
86 trabecular bone to define 3-dimensional (3D)
dosimetric models in which explicit spatial distribution
87 Current
dosimetric models of the brain and head lack the anatomi
88 Current single-region
dosimetric models of the kidneys, however, force the ass
89 The development of reliable
dosimetric models will facilitate patient-specific presc
90 ity concentration ratio determinations for 2
dosimetric models: using both male and female and male-o
91 approaches may alleviate the consequences of
dosimetric nonuniformity.
92 ith direct dose calculations using published
dosimetric organ values for (131)I-MIBG and (90)Y-DOTATO
93 icate that mean dose may be used as the sole
dosimetric parameter on the lesion level.
94 , factors impacting disease progression, and
dosimetric parameters impacting treatment toxicity.
95 Dosimetric parameters including V15, V20, V30 (percent l
96 The study aimed to compare the
dosimetric parameters to target dose coverage and the cr
97 CT imaging and
dosimetric parameters were found to be poor predictors o
98 macrophages, results show that the achieved
dosimetric performance is comparable with relatively exp
99 Surface dose was estimated on a CT
dosimetric phantom by using thermoluminescent dosimetric
100 n facilitate both placement verification and
dosimetric planning for gynecologic brachytherapy.
101 images for device placement verification and
dosimetric planning for gynecologic brachytherapy.
102 From a
dosimetric point of view, an administered dose of 200 MB
103 The favorable safety, imaging, and
dosimetric profile makes (18)F-FET-betaAG-TOCA a promisi
104 These estimates were used to generate
dosimetric projections for radioimmunotherapy with (90)Y
105 Dosimetric projections for radioimmunotherapy with (90)Y
106 cal 99mTc-EC-C225 appears to have reasonable
dosimetric properties for a diagnostic nuclear medicine
107 used to evaluate tracer biodistribution and
dosimetric properties, time-activity curves, and the sta
108 adiotracers with optimal pharmacokinetic and
dosimetric properties.
109 a and scaled from 111In-CC49 to 90Y-CC49 for
dosimetric purposes.
110 A number of
dosimetric quantifiers have been described.
111 s review, we will focus on the importance of
dosimetric quantifiers in predicting freedom from bioche
112 chemical recurrence and one or both of these
dosimetric quantifiers.
113 This resulted in personnel radiation
dosimetric readings below measurable levels in all cases
114 Statistically significant
dosimetric relationships were established with cataract,
115 reference radiochemical was quantitated as a
dosimetric relative advantage factor (RAF).
116 es the sparing of BS/SC without compromising
dosimetric requirements of other involved structures for
117 stigate differences between patient-specific
dosimetric results obtained using Monte Carlo methodolog
118 tumors is largely based on data derived from
dosimetric,
retrospective, or small prospective studies.
119 the population and the environment using the
dosimetric scheme of the WHO and the interactive tool ER
120 uring is consistent with a mechanism for the
dosimetric sensing of NO2 and other reactive gases by Cu
121 The
dosimetric sensors are selective to ppm levels of CO and
122 ificity testing, in vivo biodistribution and
dosimetric studies were performed in healthy nude mice v
123 Twelve consecutive patients referred for a
dosimetric study and subsequent radioiodine treatment of
124 l is an image-guided personalized predictive
dosimetric technique developed by our institution, integ
125 However,
dosimetric thresholds for toxicity to these tissues from
126 osimetric phantom by using thermoluminescent
dosimetric (
TLD) and CT pencil chamber measurements.
127 univariate analysis, there were no tumor or
dosimetric treatment characteristics that were found to
128 experiments were performed to determine the
dosimetric trends of PS expression caused by nsPEF as a
129 ) as 450 L/kg lipid, which is independent of
dosimetric units.
130 age only one half of that predicted from the
dosimetric uptake in thyroid remnants after surgery, eve
131 n clinical trial of PCa and showed favorable
dosimetric values.